Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Pancreas (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 9.7 (9.7, 9.8) N/A 38,462 73.9
Wyoming 6 8.4 (7.4, 9.4) 46 (23, 49) 62 74.7
Wisconsin 6 10.5 (10.2, 10.9) 8 (4, 21) 807 75.4
West Virginia 6 9.9 (9.3, 10.5) 23 (6, 37) 259 75.9
Washington 5 10.1 (9.8, 10.4) 18 (8, 28) 915 77.3
Virginia 6 8.8 (8.5, 9.1) 41 (33, 46) 921 70.7
Vermont 6 9.2 (8.3, 10.1) 35 (9, 48) 83 71.9
Utah 3 8.5 (8.0, 9.0) 43 (32, 48) 239 75.4
Texas 3 8.8 (8.7, 9.0) 40 (35, 44) 2,583 69.2
Tennessee 6 8.8 (8.5, 9.0) 42 (34, 46) 752 69.6
South Dakota 6 10.4 (9.5, 11.3) 11 (1, 36) 115 77.6
South Carolina 6 9.8 (9.5, 10.2) 25 (12, 34) 669 73.6
Rhode Island 6 10.4 (9.7, 11.2) 10 (1, 33) 146 76.5
Puerto Rico 6 5.3 (5.0, 5.6) N/A 230 63.1
Pennsylvania 6 11.1 (10.9, 11.3) 3 (1, 8) 1,977 76.5
Oregon 6 9.3 (9.0, 9.7) 33 (23, 41) 515 73.3
Oklahoma 6 8.4 (8.0, 8.8) 45 (37, 48) 406 70.2
Ohio 6 10.0 (9.8, 10.2) 22 (12, 29) 1,532 72.7
North Dakota 6 8.8 (8.0, 9.8) 39 (14, 48) 80 76.1
North Carolina 6 10.1 (9.9, 10.4) 19 (9, 27) 1,327 77.1
New York 3 11.2 (11.0, 11.4) 1 (1, 7) 2,797 77.6
New Mexico 3 7.2 (6.7, 7.7) 49 (48, 49) 198 62.6
New Jersey 3 11.1 (10.8, 11.3) 4 (1, 9) 1,259 74.7
New Hampshire 6 9.8 (9.2, 10.5) 26 (6, 39) 185 72.6
Nebraska 6 9.6 (9.0, 10.2) 28 (11, 42) 222 73.0
Montana 6 9.2 (8.5, 10.0) 34 (13, 47) 134 74.8
Missouri 6 9.6 (9.3, 9.9) 27 (18, 36) 764 73.4
Mississippi 6 10.3 (9.9, 10.8) 13 (4, 28) 383 75.8
Minnesota 6 9.4 (9.1, 9.8) 30 (21, 39) 657 67.4
Michigan 6 10.2 (9.9, 10.4) 16 (8, 26) 1,345 74.2
Massachusetts 3 10.4 (10.1, 10.7) 12 (5, 23) 920 74.4
Maryland 6 9.9 (9.6, 10.2) 24 (11, 32) 734 72.8
Maine 6 9.5 (8.9, 10.1) 29 (12, 43) 197 70.1
Louisiana 3 11.0 (10.7, 11.5) 5 (1, 11) 622 78.4
Kentucky 3 10.1 (9.7, 10.5) 21 (7, 29) 577 76.0
Kansas 6 9.0 (8.5, 9.4) 38 (27, 46) 321 76.5
Iowa 3 10.6 (10.1, 11.0) 7 (1, 24) 433 78.0
Illinois 3 10.5 (10.2, 10.7) 9 (5, 19) 1,640 74.8
Idaho 3 10.3 (9.7, 11.0) 14 (1, 32) 216 75.8
Hawaii 3 10.1 (9.5, 10.8) 20 (2, 36) 193 74.1
Georgia 3 10.7 (10.4, 10.9) 6 (3, 16) 1,258 80.6
Florida 6 9.4 (9.3, 9.6) 31 (25, 36) 2,990 72.6
District of Columbia 6 10.2 (9.1, 11.3) 15 (1, 43) 70 68.1
Delaware 6 10.1 (9.4, 11.0) 17 (1, 38) 139 73.8
Connecticut 3 11.1 (10.7, 11.6) 2 (1, 11) 534 79.9
Colorado 6 8.5 (8.2, 8.8) 44 (37, 48) 544 73.6
California 3 9.1 (9.0, 9.3) 36 (31, 40) 4,077 75.5
Arkansas 6 9.1 (8.7, 9.6) 37 (23, 44) 353 73.3
Arizona 6 8.2 (7.9, 8.4) 48 (42, 48) 767 68.4
Alaska 6 9.4 (8.3, 10.5) 32 (5, 48) 69 72.6
Alabama 6 8.3 (8.0, 8.6) 47 (40, 48) 530 64.3
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 04/19/2024 11:29 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
3 Source: SEER November 2022 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top